Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclopiroxolamine 1% Foam vs Ciclopiroxolamine 1.5% Shampoo for Moderate Seborrheic Dermatitis of the Scalp
2008-008353-35Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciclopirox in seborrheic dermatitis (SD) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Sum score of seborrheic dermatitis at day 28. Started Mar 2009; status: completed.
02
Drugs
ciclopirox
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on 2008-008353-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008353-35.